Castle Biosciences, Inc. (CSTL)

NasdaqGM • Currently up 0.54 (+2.20%) in today's trading session

1 member of Congress has disclosed 1 trade in Castle Biosciences, Inc. (CSTL) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 21 December 2020. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

Castle Biosciences, Inc. is currently trading at $25.03, positioned at 35% of its 52-week range ($14.59 – $44.28).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$25.03
24h Change
+0.54 (+2.20%)
52 Week Range
$14.59—$44.28
View on NASDAQ

Castle Biosciences, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CSTL

Select to highlight on chart
1 transactions
Compliance: 100%
Josh Gottheimer21 Dec 20207 Jan 2021PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$757.41M

Volume

68.62K

Beta

1.19

P/E Ratio

-30.12

Fundamentals

EPS

$-0.83

Div. Yield

—

Open

$24.53

Day Range

$24.15 — $25.11

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
Derek J. Maetzold
IPO Date
2019-07-25
Website
castlebiosciences.com

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identif...

Earnings

Next Report

Q1 2026

6 May

EPS Est.

$-0.49

Rev. Est.

$79.2M

Days Until

5

Recent Quarters

Q4 202526 Feb
EPS$-0.08
Beat 65.2%
Q3 20253 Nov
EPS$-0.02
Beat 94.1%
Q2 20254 Aug
EPS$0.15
Beat 129.4%
Q1 20255 May
EPS$-0.20
Miss 150.0%
Q4 202427 Feb
EPS$0.32
Beat 900.0%
Q3 20244 Nov
EPS$0.08
Beat 233.3%
Q2 20245 Aug
EPS$0.31
Beat 214.8%
Q1 20242 May
EPS$-0.09
Beat 75.7%
Q4 202328 Feb
EPS$-0.10
Beat 88.1%
Q3 20232 Nov
EPS$-0.26
Beat 71.7%
Q2 20232 Aug
EPS$-0.70
Beat 30.7%
Q1 20233 May
EPS$-1.10
Miss 37.5%
Q4 202228 Feb
EPS$-0.78
Beat 14.3%
Q3 20222 Nov
EPS$-0.77
Miss 10.0%
Q2 20228 Aug
EPS$-0.06
Beat 89.7%
Q1 20229 May
EPS$-0.80
Miss 19.4%
Q4 202128 Feb
EPS$-0.25
Beat 41.9%
Q3 20218 Nov
EPS$-0.47
Miss 34.3%
Q2 20219 Aug
EPS$-0.34
Miss 17.2%
Q1 202110 May
EPS$-0.17
Beat 22.7%
Q4 20208 Mar
EPS$-0.16
Miss 45.5%
Q3 20209 Nov
EPS$-0.23
Miss 283.3%
Q2 202010 Aug
EPS$-0.08
Beat 81.0%
Q1 202011 May
EPS$0.03
Beat 120.0%
Q4 201910 Mar
EPS$0.11
Beat 155.0%
Q3 201911 Nov
EPS$-0.31
Beat 0.0%
Q2 20193 Sept
EPS$-1.05
Miss 101.9%
Q2 201926 Jul
EPS$-0.13
Q3 201831 Dec
EPS$0.36
Q2 201830 Sept
EPS$-0.32
Q1 201830 Jun
EPS$-0.30
Q4 201731 Mar
EPS$-0.34

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

20
$198.77-0.80 (-0.40%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

GOOG

Alphabet Inc.

17
$380.43-1.51 (-0.40%)
Communication Services
Held by same politician
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.69+0.01 (+0.10%)
Held by same politician
1 politician
View Stock

Frequently Asked Questions about CSTL

Which members of Congress have traded CSTL?
1 member of Congress has disclosed 1 trade in Castle Biosciences, Inc. (CSTL) under the STOCK Act: Josh Gottheimer.
When was CSTL most recently disclosed by Congress?
The most recent CSTL disclosure was a purchase by Josh Gottheimer on 21 December 2020.
What is the total disclosed congressional trading volume for CSTL?
Members of Congress have disclosed approximately $8K in CSTL purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in CSTL?
This CSTL page updates as soon as new STOCK Act disclosures are filed for Castle Biosciences, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.